✦ LIBER ✦

334 First-in-human study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of oral cp-724, 714, a selective, small molecule inhibitor of her2 in patients with advanced cancer

✍ Scribed by P.N. Munster; A.W. Tolcher; C.D. Britten; K. Gelmon; S. Moulder; S. Minton; M. Mita; D. Noe; K.J. Pierce; S.P. Letrent

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of a HER2 tyrosine kina

✍ Feng Guo; Stephen P. Letrent; Pamela N. Munster; Carolyn D. Britten; Karen Gelmo 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 382 KB

383 First-in-human study of PF-04691502,

✍ C.D. Britten; A.A. Adjei; R. Millham; B. Houk; Z.A. Wainberg; T. Guthrie; G. Dy; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 130 KB

387 First-in-human study of PF-05212384,

✍ G.I. Shapiro; J. Molina; J. Bendell; I. Braña; J. Spicer; E. Kwak; S. Pandya; R. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

585 POSTER Phase I study of the safety a

✍ L. Lewis; N. Reddy; F. Guo; K.J. Pierce; A.J. Olszanski; S. Balan 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 60 KB

364 The first-in-human, first-in-class s

✍ T. Shimizu; A.W. Tolcher; P. LoRusso; K. Papadopoulos; A. Patnaik; L. Smith; M. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB

580 First-in-human, Safety, Pharmacokine

✍ Dienstmann, R.; Lassen, U.; Cebon, J.; Desai, J.; Brown, M.P.; Evers, S.; Su, F. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 75 KB